Global Rx Medical Food Market, by Product Type (Pills, Powders, Liquids, and Others), by Therapeutic Application (Pain Management, Sleep Disorder, Neurological Disorder, GI Disorder, Pulmonary Disorders, Metabolic Disorders, and Others), by Distribution Channel (Retail Pharmacies and Online Pharmacies), and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

  • Published On : Oct 2017 |
  • Pages : 166 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Rx Medical Food – Let Medicine Be the Food

Medical food is a category of products for dietary management or supportive therapy for specific disease or medical conditions such as pulmonary and metabolic disorders. Ingredients used in medical foods must have generally recognized as safe (GRAS) status, which is assigned to naturally found food materials. Medical food is different from nutritional food, dietary supplements, and prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and isoflavones), and may contain minerals and vitamins such as folic acid and thiamine. These products are prescribed by physicians or taken under their supervision. The U.S. Food & Drug Administration (FDA) has classified medical foods into four major categories namely, nutritional complete products, nutritionally incomplete products, formulas for metabolic disorders, and oral rehydration solutions. The U.S. FDA separately regulates medical food category under Orphan Drug Act (1988) to ensure safety of populace and curb presence of products falsely claiming to cure medical conditions. Medical food does not require premarket approval, specification as an Investigational New Drug (IND), and individual registration with the FDA. However, they are required to support all their health claims with proper laboratory and clinical studies.

Increasing regulatory support and awareness about medical food among healthcare professionals is expected to fuel market growth

The U.S. FDA amended regulations related to formulation and marketing of medical food in 2013, the category, which was previously ill-defined. The new additions clarified some issues associated with marketing and branding of medical food products. Furthermore, the U.S. FDA also states that medical food does not require prescription, rather requires to be consumed under the supervision of a medical practitioner. Furthermore, the medical food market is expected to gain traction, owing to major investments by players such as Nestlé and Danone in research and development of medical foods along with widening scope of applications such as chronic pain, and personalized medicine. Medical food currently available in the market include Axona (Accera), Limbrel, Deplin, Lofenalac, Ensure, Vasculera, and Vascazen.

The global Rx medical food market was valued at US$ 14,504.6 million in 2016 and is expected to witness a robust CAGR of 7.0% over the forecast period (2017-2025).

Figure 1. Global Rx Medical Food Market by Region-2016 (US$ Mn)

rx medical food market

Source: Coherent Market Insights Analysis (2017)

North America is expected to hold a dominant position in the Rx medical food market over the forecast period, followed by Europe and Asia-Pacific

North America accounts for the largest share in the Rx medical food market, followed by Europe and Asia-pacific. The regulatory authorities in North America and Europe have clearly defined and distinguished the medical food category. Furthermore, medical food is also being regulated in Australia and New Zealand, under Food Standards Code 2.9.5. Asia-Pacific region holds major untapped market potential with strengthening regulations in the region. The Council for Responsible Nutrition (CRN), U.S., the leading trade association for the dietary supplement and functional food industry, announced to explore and include medical food as part of its mission, in 2017. The CRN will provide a common platform for major players in the industry to work together towards the advancement of medical food and to increase awareness about medical food among healthcare practitioners and consumers. Nestlé has set out a US$ 500 Mn budget to support medical food research by 2021, which is expected to boost growth of the Rx medical food market over the forecast period.

Some major players operating in the Rx medical food market are Abbott Laboratories, Danone, Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle, Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Enzymotec ltd., AlfaSigma, and Pivotal Therapeutics.

Medical food is consumed or enterally administered under the supervision of a physician for treatment of a disease or specific dietary management. Medical food is used for various purposes such as healthy aging, maintaining brain health, and for treating chronic medical conditions, irritable bowel syndrome, and metabolic disorders. Medical food mimics therapeutic agents used in the treatment of clinical conditions such as pain, sleep disorders, and cognitive disorders. It provides relief to pain or helps treat the condition without exhibiting any risk or side effects that are usually associated with the pharmaceutical drugs. Medical food products claiming treatment of such medical conditions or any other diseases are required to support their claim with proper scientific and clinical study results. Although medical food products do not require adherence to any particular labeling requirements, any false claims or misbranding may result in legal action by the Food, Drug & Cosmetic Act (FD & C Act). Medical food varies in forms of dosage such as powders, pills, and solutions, which allows for wider availability and reach. Advancement in nutritional therapies is a result of robust support of medical food products and their wide variety of therapeutic applications, which, to a certain extent is expected to offset prescription drugs usage.

Market Dynamics

Medical food, although a prescribed product, offers various advantages over prescription drugs such as lesser side effects, lower product costs, and nutritional benefits. Leveraging the preference for convenience food formats is expected to favor long-term growth of the medical food market. Besides, personalized medicine is a developing field, wherein the patient’s genetic makeup is used to guide the prevention, diagnosis, and treatment of diseases. Medical food is expected to gain a strong foothold in the personalized medicine sector. According to a report by Personalized Lifestyle Medicine Institute, in 2013, 70% of all chronic diseases were fundamentally the results of nutrition deficiencies or imbalances, in the U.S. Such nutrition-based etiologies could be directly addressed with the help of medical foods in the initial stages of diseases, preventing further loss. Thus, management of diseases by treating individual nutritional deficiencies, increases the demand for personalized medicines. The awareness regarding  medical food and its benefits, among healthcare professionals and patients is critical for growth of the market.

Market Taxonomy

This report segments the global Rx medical food market on the basis of product type, therapeutic application, and distribution channel. On the basis of product type, the global Rx medical food market is segmented into pills, powders, liquid, and others (wafers, chewable, and bars). On the basis of therapeutic application, the market is segmented into pain management, sleep disorder, neurological disorder, GI disorder, pulmonary disorders, metabolic disorders, and others (fibrosis, dialysis, AIDS, etc.). On the basis of distribution channel, the market is segmented into retail pharmacies and online pharmacies. On the basis of geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, Africa, and Middle East.

Key features of the study:

  • This report provides in-depth analysis of Rx medical food market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global Rx medical food market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Danone, Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle, Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Enzymotec ltd., AlfaSigma, and Pivotal Therapeutics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global Rx medical food market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Rx medical food market

Detailed Segmentation:

  • Global Rx Medical Food Market, By Product Type:
    • Pills
    • Powder
    • Liquid
    • Others (wafers, chewables, bars)
  • Global Rx Medical Food Market, By Therapeutic Application:
    • Pain Management
    • Sleep Disorder
    • Neurological Disorder
    • GI Disorder
    • Pulmonary Disorders
    • Metabolic Disorders
    • Others (fibrosis, dialysis, AIDS, etc.)
  • Global Rx Medical Food Market, By Distribution Channel:
    • Retail Pharmacies
    • Online Pharmacies
  • Global Rx Medical Food Market, By Geography:
    • North America
      • By Product Type:
        • Pills
        • Powder
        • Liquid
        • Others (wafers, chewables, bars)
      • By Therapeutic Application:
        • Pain Management
        • Sleep Disorder
        • Neurological Disorder
        • GI Disorder
        • Pulmonary Disorders
        • Metabolic Disorders
        • Others (fibrosis, dialysis, AIDS, etc.)
      • By Distribution Channel:
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type:
        • Pills
        • Powder
        • Liquid
        • Others (wafers, chewables, bars)
      • By Therapeutic Application:
        • Pain Management
        • Sleep Disorder
        • Neurological Disorder
        • GI Disorder
        • Pulmonary Disorders
        • Metabolic Disorders
        • Others (fibrosis, dialysis, AIDS, etc.)
      • By Distribution Channel:
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia-Pacific
      • By Product Type:
        • Pills
        • Powder
        • Liquid
        • Others (wafers, chewables, bars)
      • By Therapeutic Application:
        • Pain Management
        • Sleep Disorder
        • Neurological Disorder
        • GI Disorder
        • Pulmonary Disorders
        • Metabolic Disorders
        • Others (fibrosis, dialysis, AIDS, etc.)
      • By Distribution Channel:
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • By Product Type:
        • Pills
        • Powder
        • Liquid
        • Others (wafers, chewables, bars)
      • By Therapeutic Application:
        • Pain Management
        • Sleep Disorder
        • Neurological Disorder
        • GI Disorder
        • Pulmonary Disorders
        • Metabolic Disorders
        • Others (fibrosis, dialysis, AIDS, etc.)
      • By Distribution Channel:
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Product Type:
        • Pills
        • Powder
        • Liquid
        • Others (wafers, chewables, bars)
      • By Therapeutic Application:
        • Pain Management
        • Sleep Disorder
        • Neurological Disorder
        • GI Disorder
        • Pulmonary Disorders
        • Metabolic Disorders
        • Others (fibrosis, dialysis, AIDS, etc.)
      • By Distribution Channel:
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Pills
        • Powder
        • Liquid
        • Others (wafers, chewables, bars)
      • By Therapeutic Application:
        • Pain Management
        • Sleep Disorder
        • Neurological Disorder
        • GI Disorder
        • Pulmonary Disorders
        • Metabolic Disorders
        • Others (fibrosis, dialysis, AIDS, etc.)
      • By Distribution Channel:
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Danone
    • Mead Johnson & Company, LLC.
    • Fresenius Kabi AG
    • Nestle
    • Primus Pharmaceuticals, Inc.
    • Targeted Medical Pharma
    • Pivotal Therapeutics
    • Enzymotec Ltd.
    • AlfaSigma

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Product Type
      • Market Snippet By Therapeutic Application
      • Market Snippet By Distribution Channel
      • Market Snippet By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • PEST Analysis
    • Impact Analysis
  4. Global Rx Medical Food Market, By Product Type, 2017 - 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Pills
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Powder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Liquid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Others (Wafers, Chewables, Bars)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  5. Global Rx Medical Food Market, By Therapeutic Application , 2017 - 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Pain Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Sleep Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Neurological Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • GI Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Pulmonary Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Metabolic Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Others (fibrosis, dialysis, AIDS, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  6. Global Rx Medical Food Market, By Distribution Channel, 2017 - 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
  7. Global Rx Medical Food Market, By Regions, 2017 - 2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017 - 2025
    • North America
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Therapeutic Application, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2017 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Abbott Laboratories*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
      • Danone
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
      • Mead Johnson & Company, LLC.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
      • Fresenius Kabi AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
      • Nestle
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
      • Primus Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
      • Targeted Medical Pharma
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
      • Pivotal Therapeutics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
      • Enzymotec Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
      • AlfaSigma
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 40 market data tables and 35 figures on "Rx Medical Food Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.